Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 2
2013 2
2016 2
2017 3
2018 3
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
House modifications for preventing malaria.
Fox T, Furnival-Adams J, Chaplin M, Napier M, Olanga EA. Fox T, et al. Among authors: napier m. Cochrane Database Syst Rev. 2022 Oct 6;10(10):CD013398. doi: 10.1002/14651858.CD013398.pub4. Cochrane Database Syst Rev. 2022. PMID: 36200610 Free PMC article. Review.
House modifications for preventing malaria.
Furnival-Adams J, Olanga EA, Napier M, Garner P. Furnival-Adams J, et al. Among authors: napier m. Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD013398. doi: 10.1002/14651858.CD013398.pub3. Cochrane Database Syst Rev. 2021. PMID: 33471371 Free PMC article. Updated.
House modifications for preventing malaria.
Furnival-Adams J, Olanga EA, Napier M, Garner P. Furnival-Adams J, et al. Among authors: napier m. Cochrane Database Syst Rev. 2020 Oct 15;10:CD013398. doi: 10.1002/14651858.CD013398.pub2. Cochrane Database Syst Rev. 2020. PMID: 33058136 Updated.
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N, Crathorne L, Varley-Campbell J, Tikhonova I, Snowsill T, Briscoe S, Peters J, Bond M, Napier M, Hoyle M. Huxley N, et al. Among authors: napier m. Health Technol Assess. 2017 Jun;21(38):1-294. doi: 10.3310/hta21380. Health Technol Assess. 2017. PMID: 28682222 Free PMC article. Review.
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long L, Medina-Lara A, Mujica-Mota R, Napier M, Hyde C. Crathorne L, et al. Among authors: napier m. Health Technol Assess. 2016 Feb;20(13):1-588, v-vi. doi: 10.3310/hta20130. Health Technol Assess. 2016. PMID: 26907163 Free PMC article. Review.
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Lee SM, Falzon M, Blackhall F, Spicer J, Nicolson M, Chaudhuri A, Middleton G, Ahmed S, Hicks J, Crosse B, Napier M, Singer JM, Ferry D, Lewanski C, Forster M, Rolls SA, Capitanio A, Rudd R, Iles N, Ngai Y, Gandy M, Lillywhite R, Hackshaw A. Lee SM, et al. Among authors: napier m. J Clin Oncol. 2017 Feb;35(4):402-411. doi: 10.1200/JCO.2016.68.1841. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893326 Free article. Clinical Trial.
16 results